2021
DOI: 10.1186/s13046-021-01877-y
|View full text |Cite
|
Sign up to set email alerts
|

SRPK1/2 and PP1α exert opposite functions by modulating SRSF1-guided MKNK2 alternative splicing in colon adenocarcinoma

Abstract: Background The Mnk2 kinase, encoded by MKNK2 gene, plays critical roles in MAPK signaling and was involved in oncogenesis. Human MKNK2 pre-mRNA can be alternatively spliced into two splicing isoforms, the MKNK2a and MKNK2b, thus yielding Mnk2a and Mnk2b proteins with different domains. The involvement of Mnk2 alternative splicing in colon cancer has been implicated based on RNA-sequencing data from TCGA database. This study aimed at investigating the upstream modulators and clinical relevance o… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

2
39
0

Year Published

2021
2021
2023
2023

Publication Types

Select...
9
1

Relationship

0
10

Authors

Journals

citations
Cited by 59 publications
(41 citation statements)
references
References 37 publications
2
39
0
Order By: Relevance
“…IHC was performed using paraffin-embedded tissue sections (4 μm), and protocol was previously described ( 24 , 25 ). Briefly, the sections were dewaxed and hydrated, followed by antigen retrieval (in 0.01 mol/L citrate buffer solution, pH 6.0, heated to boiling for 2-3 min).…”
Section: Methodsmentioning
confidence: 99%
“…IHC was performed using paraffin-embedded tissue sections (4 μm), and protocol was previously described ( 24 , 25 ). Briefly, the sections were dewaxed and hydrated, followed by antigen retrieval (in 0.01 mol/L citrate buffer solution, pH 6.0, heated to boiling for 2-3 min).…”
Section: Methodsmentioning
confidence: 99%
“…However, even patients with the same TNM stage and other clinicopathologic characteristics exhibit distinct response to adjuvant therapies and varied prognosis due to the heterogeneity (Zhai et al 2017). Therefore, more accurate predictive biomarkers have been investigated in the past decades, such as and RAS mutations and immunoscores (Koncina et al 2020;Liu et al 2021;Pagès et al 2018). The application of novel biomarkers contributes significantly to predict COAD clinical outcomes, nevertheless some patients are still misdiagnosed.…”
Section: Introductionmentioning
confidence: 99%
“…Then the cells were incubated at 37°C incubator for 4 hours and 200 μl dimethyl sulfoxide (DMSO) reagent was added into each well. Finally, the plates were shaken for 15 min and send to a microplate reader to measure absorbance at 490 nm wavelength (Liu et al 2021a). The data was obtained from three independent repeats.…”
Section: Cell Proliferation Assaymentioning
confidence: 99%